VIDEO: ‘A lot of enthusiasm’ in hidradenitis suppurativa research
Click Here to Manage Email Alerts
CLEVELAND — Hidradenitis suppurativa research has hit roadblocks including high placebo responses and difficulty in accurate assessments, according to Amit Garg, MD, professor and chair of the department of dermatology at Northwell Health.
At the Medical Dermatology Therapy Update III meeting, Garg discussed these challenges and how to best address them with Healio, as well as what is in the pipeline for future treatment options.
“Overall, there’s a lot of enthusiasm for this disease state,” he said. “We have a lot of interest, a lot of stakeholders who are really engaged in trying to address this really impactful disease on behalf of patients. While we’ve got some good options today, we are really excited about having a number of other options available in the very near future to help patients with HS.”
Collapse
Garg A. Advancements and obstacles in the treatment of hidradenitis suppurativa. Presented at: Medical Dermatology Therapy Update III; May 29-31, 2024; Cleveland.
Read more about
Click Here to Manage Email Alerts